Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Role of MRI in prostate cancer detection.

Shukla-Dave A, Hricak H.

NMR Biomed. 2014 Jan;27(1):16-24. doi: 10.1002/nbm.2934. Epub 2013 Mar 13. Review.

PMID:
23495081
2.

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.

Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E.

Health Technol Assess. 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200. Review.

3.

Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.

Penzkofer T, Tempany-Afdhal CM.

NMR Biomed. 2014 Jan;27(1):3-15. doi: 10.1002/nbm.3002. Epub 2013 Sep 3. Review.

4.

Imaging prostate cancer.

Jung AJ, Westphalen AC.

Radiol Clin North Am. 2012 Nov;50(6):1043-59. doi: 10.1016/j.rcl.2012.08.001. Review.

PMID:
23122037
5.

Role of high-field MR in studies of localized prostate cancer.

Lagemaat MW, Scheenen TW.

NMR Biomed. 2014 Jan;27(1):67-79. doi: 10.1002/nbm.2967. Epub 2013 May 24. Review.

PMID:
23703839
6.

Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.

Giannarini G, Petralia G, Thoeny HC.

Eur Urol. 2012 Feb;61(2):326-40. doi: 10.1016/j.eururo.2011.09.019. Epub 2011 Sep 28. Review.

PMID:
22000497
7.

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer.

Thompson J, Lawrentschuk N, Frydenberg M, Thompson L, Stricker P; USANZ.

BJU Int. 2013 Nov;112 Suppl 2:6-20. doi: 10.1111/bju.12381. Review.

8.

Diffusion-weighted MRI and its role in prostate cancer.

Tamada T, Sone T, Jo Y, Yamamoto A, Ito K.

NMR Biomed. 2014 Jan;27(1):25-38. doi: 10.1002/nbm.2956. Epub 2013 May 27. Review.

PMID:
23712781
9.

Multiparametric magnetic resonance imaging in the detection of prostate cancer.

Durmus T, Baur A, Hamm B.

Rofo. 2014 Mar;186(3):238-46. doi: 10.1055/s-0034-1365937. Epub 2014 Jan 22. Review.

10.

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Muller BG, F├╝tterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.

BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243. Epub 2013 Nov 13.

11.

Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.

Kayhan A, Fan X, Oto A.

Top Magn Reson Imaging. 2009 Apr;20(2):105-12. doi: 10.1097/RMR.0b013e3181c0e2fa. Review.

PMID:
20010065
12.

[MR spectroscopic imaging for evaluation of prostate cancer].

Taouli B.

J Radiol. 2006 Feb;87(2 Pt 2):222-7. Review. French.

13.

MR imaging of the prostate in clinical practice.

Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H.

MAGMA. 2008 Nov;21(6):379-92. doi: 10.1007/s10334-008-0138-y. Epub 2008 Sep 16. Review.

PMID:
18795354
14.

Prostate cancer - the role of magnetic resonance imaging.

Mocikova I, Babela J, Balaz V.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Jun;156(2):103-7. doi: 10.5507/bp.2012.025. Review.

15.

Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.

Afaq A, Koh DM, Padhani A, van As N, Sohaib SA.

BJU Int. 2011 Dec;108(11):1716-22. doi: 10.1111/j.1464-410X.2011.10256.x. Epub 2011 Jun 1. Review.

16.

Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.

Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V, Witjes JA.

Eur Urol. 2011 Jun;59(6):962-77. doi: 10.1016/j.eururo.2011.02.034. Epub 2011 Feb 23. Review.

PMID:
21367519
17.

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.

Lawrentschuk N, Fleshner N.

BJU Int. 2009 Mar;103(6):730-3. doi: 10.1111/j.1464-410X.2008.08205.x. Epub 2009 Jan 14. Review.

18.

Magnetic resonance imaging and spectroscopic imaging of prostate cancer.

Coakley FV, Qayyum A, Kurhanewicz J.

J Urol. 2003 Dec;170(6 Pt 2):S69-75; discussion S75-6. Review.

PMID:
14610414
19.

Mapping of prostate cancer by 1H MRSI.

Kobus T, Wright AJ, Scheenen TW, Heerschap A.

NMR Biomed. 2014 Jan;27(1):39-52. doi: 10.1002/nbm.2973. Epub 2013 Jun 13. Review.

PMID:
23761200
20.

Role of MRI in the diagnosis and management of prostate cancer.

Wibmer AG, Vargas HA, Hricak H.

Future Oncol. 2015;11(20):2757-66. doi: 10.2217/fon.15.206. Epub 2015 Sep 14. Review.

PMID:
26367323

Supplemental Content

Support Center